Activities:
An emerging strategy for the prevention of HPV infection and disease in males
March 2009
This supplement is sponsored by SciMed and supported by an educational grant from Merck & Co., Inc.
Human papillomavirus (HPV) has the highest incidence of all sexually transmitted infections. Infection with high-risk oncogenic HPV types is associated with anal, penile, and oropharyngeal cancers in men. Although the HPV vaccine is currently only approved for females, this newsletter explores why vaccinating men may be beneficial.
Irritable Bowel Syndrome: A Disagreeable Digestive Disorder
May 2009
This lecture was developed for the Women’s Health Annual Visit series presented in 2008.
This activity was developed solely by Omnia Education and supported by independent educational grants from Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals North America, Inc..Patients with irritable bowel syndrome (IBS) often have high rates of psychosocial distress and psychiatric disorders, such as anxiety and depression, which pose challenges in diagnosing and treatment. This lecture will provide information on how to better recognize symptoms of the disease, and implement effective treatment.
Luteal support in reproduction
May 2009
This CME/CE supplement was supported by an educational grant from Columbia Laboratories and sponsored by the American Society for Reproductive Medicine. Content has been edited and peer reviewed by Sexuality, Reproduction & Menopause (SRM).
The goal of this supplement is to provide physicians and nurses in reproductive medicine and gynecology with current perspectives on the use of progestogens in assisted reproductive technologies, in the treatment of secondary amenorrhea, in postmenopausal hormone therapy, and in recurrent pregnancy loss.
HPV: Past, present, and in practice
The Omnia CME Journal
September 2009
This supplement was submitted by Omnia Education and supported by independent educational grants from Merck & Co., Inc., and QIAGEN Inc.
New research has led to a better understanding of human papillomavirus (HPV) epidemiology and vaccination. But how can the clinician incorporate this research into a busy practice? This supplement examines target populations for HPV infections and the implementation of an office system to identify at-risk women and provide HPV vaccination into practice.
Frequently asked questions in the evaluation and management of overactive bladder
October 2009
This supplement was presented by the Warren Alpert Medical School of Brown University and supported by educational grants from Astellas Pharma US, Inc., and Pfizer Inc.
Patients are often reluctant to seek medical help for overactive bladder (OAB), due to social stigma, misconceptions that OAB is an inevitable consequence of aging, and fear that the assessment and treatment is more troublesome than the symptoms themselves.
For other CME Activities from The Journal of Family Practice
(Click Here to Continue)
Loading ...
fred klumpp |&co